Desjardins Global Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$781K Buy
10,932
+119
+1% +$8.29K 0.08% 197
2023
Q3
$750K Buy
10,813
+3,929
+57% +$297K 0.08% 207
2023
Q2
$557K Sell
6,884
-1,708
-20% -$140K 0.06% 272
2023
Q1
$693K Buy
8,592
+46
+0.5% +$3.7K 0.09% 191
2022
Q4
$639K Buy
8,546
+602
+8% +$42.9K 0.1% 193
2022
Q3
$512K Buy
7,944
+1,050
+15% +$72.7K 0.06% 224
2022
Q2
$477K Buy
6,894
+66
+1% +$4.9K 0.06% 234
2022
Q1
$524K Sell
6,828
-184
-3% -$13.2K 0.05% 256
2021
Q4
$536K Buy
+7,012
New +$515K 0.05% 270

Other funds holding HOLX

Desjardins Global Asset Management's HOLX Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Hologic (HOLX) stake by 1.1% in Q4 2023, buying an estimated $8.29K and bringing the position to 10,932 shares worth $781K. The position accounts for 0.08% of the portfolio, ranked #197.

Desjardins Global Asset Management first reported a position in HOLX in Q4 2021 and has held it in 9 quarters since. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Desjardins Global Asset Management held 10,932 shares of Hologic worth $781K as of Q4 2023.
  • Desjardins Global Asset Management bought 119 Hologic shares in Q4 2023, an estimated $8.29K.
  • Hologic made up 0.08% of Desjardins Global Asset Management's portfolio in Q4 2023, its #197 holding.
  • Desjardins Global Asset Management first reported a position in Hologic in Q4 2021 and has held it in 9 quarters since.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.